ReShape Lifesciences Stock Forum

$ReShape Lifesciences (RSLS.US)$
ReShape Lifesciences (RSLS) reported Q3 2024 financial results, showing revenue growth of 16.6% over Q2 2024 and 6.4% year-over-year to $2.3 million.
The company achieved a 40.6% reduction in operating expenses for the first nine months of 2024 compared to 2023.
Gross profit margin improved to 62.8% in Q3 2024.
The company entered into a merger agreement with Vyome Therapeutics and an asset purchase agreement with Biorad Medisys for $5.16 million.
ReSha...

$ReShape Lifesciences (RSLS.US)$ Reuters· just
ReShape Lifesciences: Entered Into Merger Agreement With Vyome Therapeutics & Asset Purchase Agreement With Biorad Medisys

$ReShape Lifesciences (RSLS.US)$ Reuters
4 mins ago
ReShape Lifesciences® Receives Health Canada Approval for Its Next-Generation Lap-Band® 2.0 Flex

$ReShape Lifesciences (RSLS.US)$
ReShape Lifesciences® Receives Health Canada Approval for its Next-Generation Lap-Band® 2.0 FLEX
ReShape Lifesciences (Nasdaq: RSLS) has received Health Canada approval for its next-generation Lap-Band® 2.0 FLEX and Tubing Kit. The enhanced device features new Flex technology that acts as a relief valve, allowing larger food pieces to pass through more easily by temporarily relaxing before returning to its resting diameter. Like its predecessor, the device can...

$ReShape Lifesciences (RSLS.US)$ and spoofing wtf

$ReShape Lifesciences (RSLS.US)$
pumped to 11 dayumm